Agilvax: Research Associate

AgilVax, Inc. is a biopharmaceutical company developing antibody-based products to treat multiple types of cancer in combination with chemotherapy, checkpoint and KRAS inhibitors.

We are seeking a highly capable and motivated research associate to develop novel antibody-based therapeutics for our oncology pipeline. The candidate will generate and maintain hybridomas and cell lines, characterize antibodies using a variety of techniques, and assist in the development of in vitro and in vivo studies. Specific position level will be commensurate with applicant’s experience.


  • Generate, screen and maintain hybridomas
  • Experience in antibody cloning, expression and characterization
  • Conduct research to enable selection of therapeutic lead antibodies including antibody-drug conjugates
  • Conduct research to support target validation
  • Demonstrated hands-on experience with tissue culture, antibody-based assays, and flow cytometry
  • Experience in cancer biology is a bonus
  • Maintain detailed and accurate laboratory records and present results at group meetings
  • Capable of handling multiple projects simultaneously with limited supervision
  • Ability to communicate effectively through oral and written presentations
  • Strong interpersonal and organizational skills


Qualifications: M.S. in molecular biology, biochemistry, biophysics, immunology or a related discipline with 3+ years of experience or B.S. in molecular biology, biochemistry, biophysics, immunology or a related discipline and 5+ years of lab research experience. Qualified candidates must be legally authorized to be employed in the United States. Agilvax does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status)

Interested candidates should reach out directly to Joe Patti at

Leave A Reply:

(optional field)

No comments yet.